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Coltiviruses are tickborne viruses of the genus
Coltivirus. The type species, Colorado tick fever virus (from
North America), has been isolated from patients with flulike
syndromes, meningitis, encephalitis, and other severe
complications. Another coltivirus, Eyach virus, has been
isolated from ticks in France and Germany and incriminat-
ed in febrile illnesses and neurologic syndromes.
Seadornaviruses are endemic in Southeast Asia, particu-
larly Indonesia and China. The prototype virus of the
genus, Banna virus (BAV), has been isolated from many
mosquito species, humans with encephalitis, pigs, and cat-
tle. Two other seadornaviruses, Kadipiro and Liao Ning,
were isolated only from mosquitoes. The epidemiology of
seadornaviruses remains poorly documented. Evidence
suggests that BAV is responsible for encephalitis in
humans. Infection with BAV may be underreported
because it circulates in regions with a high incidence of
Japanese encephalitis and could be misdiagnosed as this
disease. 
V
ertebrate viruses belonging to the family Reoviridae
and having 12-segmented dsRNA genomes at one
time were classified in the genus Coltivirus (Colorado tick
virus [CTFV]). At the time the genus was created, it
included tickborne and mosquitoborne viruses. Presently,
the genus Coltivirus contains only CTFV, California hare
coltivirus (CTFV-Ca), which is considered a serotype of
CTFV, Eyach virus (EYAV), which is distinct from CTFV,
and Salmon River virus (SRV), which may be a serotype
of both CTFV and CTFV-Ca. Alternatively, analysis of
sequence data and antigenic properties of the mosquito-
borne viruses led to their reassignment to a new genus des-
ignated  Seadornavirus (Southeast Asian dodeca RNA
virus) (1,2).
Coltiviruses
Historical Aspects and Epidemiology
Tickborne vertebrate viruses include CTFV isolated
from humans and ticks, EYAV isolated from ticks, CTFV-
Ca isolated from a hare (Lepus californicus, black-tailed
jackrabbit) in northern California, and SRV isolated from a
person in Idaho. Many mosquitoborne viruses were also
considered tentative species in this genus, including Banna
virus (BAV) from humans. The tickborne viruses in this
genus have many distinctive features and sequence data
have led to a reevaluation of their taxonomic status.
Coltiviruses have been isolated from ticks of the fami-
ly  Ixodidae and from rodents and humans. CTFV is
endemic in northwestern North America, where it causes
CTF, a human disease initially confused with a mild form
of Rocky Mountain spotted fever, which is caused by
Rickettsia rickettsii. The causative agent was isolated by
Florio and others (3) in 1946 from human serum by injec-
tion into adult hamsters. The virus was adapted to egg and
mice, and suckling mice became the routine isolation sys-
tem for CTFV (3–5). 
CTF is found in the Rocky Mountain region of the
United States and in Canada. The virus distribution close-
ly matches that of its vector Dermacentor andersoni.
CTFV-Ca, identified as strain S6-14-03, was isolated from
the blood of the white hare, L. californicus, in California
(outside the range of D. andersoni) (6). Antibodies to
CTFV antigen have been detected in sera of humans in
South Korea (C. Calisher, pers. comm.). SRV was isolated
from a patient with moderately severe CTF-like illness in
Idaho.
EYAV was isolated in Europe in 1976 from Ixodes rici-
nus ticks (EYAV-Gr) and in 1981 from I. ricinus (EYAV-
Fr578) and I. ventalloi (EYAV-Fr577) (7). Its antigenic
relationship to CTFV was established by a complement-
fixation assay (7). Genome sequence analysis showed that
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Serologic surveys in France identified antibodies to
EYAV in 1.35% of animals, including the European rabbit
(Oryctolagus cunniculus), mice, mountain goats, domestic
goats, sheep, and deer (9). The presence of EYAV was sus-
pected in Europe because anti-EYAV antibodies were
detected in patients with neurologic disorders. However,
the natural cycle of the virus is still unclear, and whether it
circulates continuously in Europe is not known, although
the rabbit O. cunniculus is suspected of being main host
(6,9). In 2003, the virus was reisolated from I. ricinus ticks
in Germany (10). 
Vectors, Host Range, and Transmission
Ticks are the principal vectors of coltiviruses. CTFV is
transmitted by the wood tick D. andersoni, but other ticks
such as D. occidentalis, D. albopictus, D. arumapertus,
Haemaphysalis leporispalustris,  Otobius lagophilus,
Ixodes sculptus, and I. spinipalpis are also infected with
the virus. EYAV has been isolated from I. ricinus and I.
ventalloi (7). Ticks become infected through blood meals
from an infected vertebrate host. CTFV is transmitted
transstadially, but not transovarially. Infected larvae and
nymphs can hibernate, and the nymphal and adult ticks
become persistently infected. In certain rodents viremia
can persist for >5 months. These ticks and rodents may
provide hosts by which the virus could overwinter. The
prevalence of viremia in rodents in a virus-endemic area
ranges from 3.5% to 25%, and the prevalence in ticks
ranges from 10% to 25% (7). CTFV has a wide host range
that includes ground squirrels, chipmunks, wild mice,
wood rats, wild rabbits and hares, porcupines, marmots,
deer, elk, sheep, and coyotes.
Person-to-person transmission of CTFV can occur by
blood transfusions (11). This virus is included on the list of
agents screened before bone marrow transplantation in the
United States (www.guideline.gov/summary/summary.
aspx?doc_id=2573&nbr=1799&string=pertussis).
Prolonged viremia observed in humans and rodents is due
to the intraerythrocytic location of virions, which protects
them from immune clearance (12–14). 
Properties, Genome, and Replication
Coltivirus particles are ≈80 nm in diameter and have a
core  ≈50 nm in diameter. Electron microscopic studies
(8,15) have shown particles with a relatively smooth sur-
face capsomeric structure and icosahedral symmetry
(Figure 1A). Most viral particles are nonenveloped, but a
few acquire an envelope structure during passage through
the endoplasmic reticulum (8,15). The buoyant density of
CTFV in CsCl is 1.36–1.38 g/cm3. The virus is stable
between pH 7.0 and 8.0 but loses infectivity at pH 3.0.
CTFV can be stored at 4°C for 2–3 months in 50% fetal
calf serum, 0.2 mmol/L Tris-HC1, pH 7.8, or for years at
–80°C. Upon heating to 55°C, CTFV loses its infectivity.
The virus is stable when treated with nonionic detergents
(such as Tween 20) or with organic solvents (such as Freon
113 or its ozone-friendly substitute Vertrel XF), but viral
infectivity is abolished by treatment with sodium deoxy-
cholate or sodium dodecyl sulfate (16,17).
The genome consists of 12 dsRNA segments designat-
ed Seg-1 to Seg-12 in order of reduced molecular weight
as observed during agarose and polyacrylamide gel elec-
trophoresis. The genome contains ≈29,000 bp and seg-
ment size ranges from 675 bp to 4,350 bp (18,19). The
genomic dsRNA of CTFV has an electropherotype
(Figure 2A) similar to that of CTFV-Ca. CTFV produces
a cytopathic effect (CPE) in mammalian cells, including
human carcinoma cells, monkey kidney cells (buffalo
green monkey [BGM] and Vero), hamster kidney cells
(BHK-21), and mouse fibroblasts (L-929). Cells infected
with CTFV develop granular matrices that contain virus-
like particles in the cytoplasm. These structures are simi-
lar to viral inclusion bodies produced during orbivirus
infections (15). In addition, bundles of filaments (tubules)
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Figure 1. Negative contrast electron micrographs of A) Colorado
tick fever virus and B) Banna virus (BAV). C) Thin section of BAV-
infected C6/36 cells showing viral particles (arrows) in vacuolelike
structures.characterized by cross-striations and kinky threads are
found in the cytoplasm and, in some cases, in the nucleus
of infected cells (8,15,17). These tubules may also be
comparable to those found in orbivirus-infected cells.
More than 90% of virus particles remain associated with
debris after cell disruption. 
Sequence analysis of coltivirus genomes has shown
that segment 6 of viral protein 6 (VP6) of CTFV is homol-
ogous to segment 7 (VP7) of EYAV (Figure 3). The amino
acid sequence (residues 370–490) of VP7 of EYAV
showed 50% similarity to the sarcolemmal-associated pro-
tein of the European rabbit O. cunniculus, which may be
the major host of EYAV. By comparison, VP6 of CTFV
showed no similarity with this rabbit protein (8), which
may be the result of insertion of a sequence encoding a
lagomorph protein into segment 7 of EYAV. Reading
through a stop codon, which is common in retroviruses and
alphaviruses, was reported in coltiviruses, particularly in
segment 9, where long and short proteins are produced
from a single open reading frame (20). 
Virus Relationships
Antigenic variation between CTFV strains is low, espe-
cially between strains from humans (21). Distinct CTFV
serotypes are difficult to define (22), and immunity to rein-
fection has been observed (23). CTFV from North
America and EYAV from Europe show little cross-reactiv-
ity in neutralization assays. CTFV-Ca cross-reacted with
CTFV, but not with EYAV, and may be a serotype of
CTFV. Two species of coltiviruses have been identified:
CTFV, with 2 serotypes represented by CTFV-F1 and
CTFV-Ca, and EYAV. Overall identities between
nucleotide sequences from segments 9, 10, 11, and 12 of
CTFV strains range from 90% to 100%: 97%–100% for
segment 9, 96%–99% for segment 10, 90%–94% for seg-
ment 11, and 94%–96% for segment 12. The degree of
identity between nucleotide sequences of segments 1–12
of CTFVand EYAVisolates ranges from 55% to 88% (19). 
The genome of CTFV contains 29,174 nucleotides, and
that of EYAV contains 29,210 nucleotides (18). All 12 seg-
ments of CTFV and EYAV have conserved sequences that
are located at their termini. The motifs 5′-G/CACAUU-
UG-3′ and 5′-UGCAGUG/C-3′ are found in the 5′ and 3′
noncoding regions of CTFV, respectively, and the motifs
5′-GACAA/UUU-3′ and 5′-UGC/UAGUC-3′ are found in
these noncoding regions in EYAV. The 5′ and 3′ terminal
trinucleotides of all segments in both viruses are inverted
complements (8).
Genome characterization has helped shed light on the
origin of EYAV. Genetic findings support the hypothesis
that EYAV was derived from a CTFV-like ancestor virus
that was introduced into Europe through Asia when lago-
morph ancestors migrated from North America 5–50 mil-
lion years ago (8). The antigenic and genetic relationships
between CTFVand EYAVare further corroborated by their
identical morphologic features, as analyzed by electron
microscopy (8).
Clinical Features
Infection of humans with CTFV is characterized by
abrupt onset of fever, chills, headache, retroorbital pain,
photophobia, myalgia, abdominal pain, and generalized
malaise. Diphasic or triphasic febrile patterns have been
observed, usually lasting for 5 to 10 days. Severe forms of
the disease that involve infection of the central nervous
system (CNS) or hemorrhagic fever, pericarditis,
myocarditis, and orchitis have been rarely observed, main-
ly in children. Severity is sufficient to result in hospitaliza-
tion of ≈20% of patients. Offspring of mice experimentally
infected with CTFV showed teratogenic effects (24).
Mother-to-infant transmission has been reported in preg-
nant women.
The incidence of complications in different reports of
infection with CTFV has been reported as <7% (23–26).
CTFV causes leukopenia (65% of infected humans), with
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Figure 2. Electropherotypes of coltiviruses and seadornaviruses
on 1% agarose gels. A) Colorado tick fever virus (CTFV-Fl) and
California hare coltivirus (CTFV-Ca). B) Banna virus (BAV) and
Kadipiro virus (KDV).mean leukocyte counts of 900/µL to 3,900/µL, and throm-
bocytopenia, with platelet counts of 20,000/µLt o
95,000/µL (27). Patients with neurologic disorders
(meningitis, meningoencephalitis, encephalitis) show lym-
phocyte infiltration of cerebrospinal fluid (CSF), and the
virus has been isolated from CSF. 
CTFV infections have been confused with other tick-
borne diseases such as Rocky Mountain spotted fever (a
rickettsial disease), tularemia, relapsing fever, and Lyme
disease. However, rash and leukocytosis distinguish Rocky
Mountain spotted fever from CTF. Signs in the CNS con-
fuse CTF with other causes of viral meningitis and
encephalitis, including St. Louis encephalitis virus,
Western equine encephalitis virus, and enteroviruses. 
CTFV can be isolated from blood because it is present
in circulating erythrocytes for as long as 4 months (28),
and it infects the hematopoietic progenitor cells and
remains sheltered in erythrocytes after maturation.
Intracerebral injection of blood into suckling mice is con-
sidered the most sensitive isolation system. Reverse tran-
scription–polymerase chain reaction (RT-PCR) was
developed for diagnosis of CTFV infection, and this
method detected human and tick virus isolates >3 days
postinfection in experimentally infected mice (29). As lit-
tle as 1 genome could be detected by using a PCR assay
(29).
Serologic diagnostic methods based on CTFV-infected
cell cultures have also been developed (29). These include
1) a complement-fixation test that is relatively insensitive
because in 25% of patients complement-fixing antibodies
are not detected and in 75% of patients these antibodies
appear late after infection; 2) a seroneutralization assay for
detection neutralizing antibodies that appear 14–21 days
after onset of disease; 3) an immunofluorescence assay
that uses CTFV-infected BHK-21 or Vero cells and is an
easy and rapid test for detecting anti-CTFVantibodies; and
4) an enzyme-linked immunosorbent assay (ELISA) for
immunoglobulin M (IgM) and IgG that appear concurrent-
ly or a few days after neutralizing antibodies (peak 30–40
days after infection), However, IgM titers decrease sharply
after day 45. An ELISA based on recombinant VP7 and a
Western blot based on synthetic VP12 showed good sensi-
tivity in detecting antibodies to CTFV (29,30).
A complement fixation assay has been developed for
detection of EYAV (6). It detected anti-EYAV antibodies in
158 Czechoslovakian patients with encephalitis in whom
tickborne encephalitis had been diagnosed. This popula-
tion was also tested for tickborne encephalitis viruses
(Kemerovo, Lipovnik, or Tribec) and antibodies to EYAV.
Seventeen serum specimens (11%) had only anti-EYAV
antibodies. The same test identified anti-EYAV antibodies
in 8 (17%) of 47 patients with polyradiculoneuritis and
meningopolyneuritis (31). Recently, an ELISA based on
recombinant VP6 of EYAV was developed. This test selec-
tively identified anti-EYAV antibodies (32). An RT-PCR
assay based on the sequence of genome segment 12 has
also been developed for specific detection of EYAV (29). 
Seadornaviruses
Historical Aspects and Epidemiology
BAV is the type species of the genus Seadornavirus
(19) that includes Kadipiro virus (KDV) and Liao Ning
virus (LNV). Vectors for this genus include Anopheles,
Culex, and Aedes mosquitoes. These viruses are endemic
in Southeast Asia, particularly Indonesia and China (2).
BAV was first isolated in 1987 from CSF (2 isolates) and
sera (25 isolates) of patients with encephalitis in southern
China (Yunnan Province). Numerous isolates were also
obtained from other patients with encephalitis (33,34). A
virus described as an isolate of BAV was identified in
western China (Xinjiang Province) from patients with
fever and flulike manifestations (35). Virus isolates from
pigs and cattle with genomes having the same electro-
pherotype as BAV were also reported (34). The isolation
from mosquitoes of 12 segmented dsRNA viruses anti-
genically related to BAV has been reported in various
provinces of China, including Beijing, Gansu, Hainan,
Henan, and Shanshi, and in central Java, Indonesia. BAV
is now classified as a biosafety level 3 arboviral agent
(www.cdc.gov/od/ohs/biosfty/bmbl4/bmbl4s74.htm).
Vectors, Host Range, and Transmission
Seadornaviruses have been isolated from Culex vishnui,
Cx. fuscocephalus,  Anopheles vagus, An. aconitus,  An.
subpictus, and Aedes dorsalis. BAV, KDV, and LNV are
found in tropical and subtropical regions where other mos-
quitoborne viral diseases, especially JE and dengue, are
endemic. Several cases of encephalitis in China have been
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Figure 3. Comparison of nucleotide and amino acid sequences of
genome segments of viral proteins (VP) and dsRNA segments (S)
of Colorado tick fever virus (CTFV) and Eyach virus (EYAV). NTP,
nucleoside triphosphatase.diagnosed as Japanese encephalitis (JE) without any detec-
tion of JEV or specific anti-JEV antibodies. Recently, 89
paired serum samples from these patients were tested by
ELISA for anti-BAV IgG antibodies. At least a 4-fold (up
to 16-fold) increase in IgG antibodies was observed in 7
cases. An additional 1,141 serum specimens of patients
from a large number of health institutes in China, who sup-
posedly had JE or viral encephalitis, were tested for anti-
BAV IgM antibodies; 130 samples were positive (34).
Seadornaviruses were shown to replicate in adult labo-
ratory mice and were detected in infected mouse blood at
3 days postinfection until day 5 postinfection (36). To date,
BAV has been isolated only from humans, and KDV and
LNV have been isolated only from mosquitoes. 
Properties, Genome, and Replication
Seadornavirus has 7 structural proteins, 5 of which are
present in the core (37). The viruses are icosahedral with a
diameter of 60–70 nm, and the core has a diameter of ≈50
nm. The surface of virus has spikes (Figure 1B) that are
similar to those of rotaviruses. The viruses are stable at pH
7.0, and acidity decreases their infectivity (which is lost at
pH 3.0). Purified virus can be stored at 4°C or for long
periods at –80°C. Viral infectivity is decreased consider-
ably upon heating to 55°C. Organic solvents such as Freon
113 or Vertrel XF can be used for purification of viral par-
ticles from cell lysates and do not affect infectivity. 
The seadornavirus genome consists of 12 segments of
dsRNA known as Seg-1 to Seg-12 in order of decreasing
molecular mass observed by gel electrophoresis (Figure
2B). The genome of BAV or KDV is ≈21,000 bp, and the
segment length ranges between 862 bp and 3,747 bp (2).
During replication, viruses are found in the cell cytoplasm
within vacuolelike structures (Figure 1C) that are believed
to be involved in morphogenesis (37). 
Seadornavirus isolates replicate in various mosquitoes
cell lines such as C6/36 and AA23 (both from Ae. albopic-
tus), A20 (Ae. aegypti), and Aw-albus (Ae. W. albus). More
than 40% of the virus particles are released into the culture
medium before cell death and massive CPE (fusiform
cells). Infected cells are not lysed, and the virus leaves
cells by budding, thus acquiring a temporary envelope
(37). Late infection results in cell lysis from cell death.
Intracellular radiolabeling of viral polypeptides has shown
termination of host cell protein synthesis (37). 
In addition to its capacity to replicate in a large number
of mosquito cell lines, LNV is the only seadornavirus that
replicates in a variety of transformed or primary mam-
malian cell lines such as Hep-2 (human carcinoma cells),
BGM, Vero, BHK-21, L-929, and MRC-5 (human lung
fibroblasts). Infection with LNV results in a massive lytic
effect and also kills adult mice. 
Relationships among Seadornaviruses 
and other Reoviridae
Antigenic relationships between seadornaviruses were
investigated by using mouse immune sera. BAV from
southern China and Indonesia and KDV from Indonesia
are classified as distinct species (1) and show no cross-
reactivity in neutralization tests. These viruses are also
antigenically distinct from LNV. Antigenic variations were
observed in many isolates from China that showed cross-
reactivity with BAV. 
Amino acid sequence analysis identified BAV, KDV,
and LNV as 3 distinct species (2). Identities between
homologous proteins ranged from 24% to 42%, with the
highest value found in the polymerase gene. Analysis of
different BAV isolates has shown the existence of 2 geno-
types identified as genotype A (represented by isolates
BAV-Ch [China] and BAV-In6423 [Indonesia]) and geno-
type B (represented by isolates BAV-In6969 and BAV-
In7043 [Indonesia]). This grouping is based on sequences
of segments 7 and 9: amino acid sequences of segment 7
show an identity of 72% between the 2 genotypes, while
those of segments 9 show an identity of 41%. All other
proteins among BAV isolates have identities ranging from
83% to 100% (1,19). Based on a seroneutralization assay,
these 2 genotypes were found to represent 2 serotypes of
BAV (38).
Sequence comparison of the structural proteins of BAV
(VP1, VP2, VP3, VP4, VP8, VP9, and VP10) (Figure 4)
with those of other members of the Reoviridae have shown
that VP9 and VP10 of BAV have similarities to VP8 and
VP5 subunits of the outer coat protein VP4 of rotavirus A
(37). This finding was further confirmed when the crystal
structure of BAV VP9 was determined and showed struc-
tural similarities to rotavirus VP8 (38). In addition, VP3 of
BAV, which is the guanylyltransferase of the virus (39),
Coltiviruses and Seadornaviruses
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Figure 4. Comparison of nucleotide and amino acid sequences of
genome segments of viral proteins (VP) and dsRNA segments (S)
of Banna virus (BAV) and Kadipiro virus (KDV). NTP, nucleoside
triphosphatase.exhibited significant amino acid identity with the VP3 of
rotavirus, which is also a guanylyltransferase. These data
suggest an evolutionary relationship between rotaviruses
and seadornaviruses (Figure 5). 
Clinical Features
The only seadornavirus isolated from humans and asso-
ciated with human disease is BAV. Persons infected with
BAV exhibited flulike symptoms, myalgia, arthralgia,
fever, and encephalitis (33). A serologic diagnostic assay
was developed (40) based on VP9, the outer coat protein
responsible for cell attachment and neutralization. Patients
infected with BAV have shown a 4-fold increase in anti-
BAV antibody titers in paired serum specimens tested by
ELISA, showing an immune response to the virus
infection (34). Molecular diagnostic assays have also been
designed for detecting BAV and KDV (36). RT-PCR
assays were validated in infected murine model, in which
the genome could be detected as early as 3 days postinfec-
tion. PCR assays identify differences between genotypes A
and B of BAV based on the length of the amplicon
obtained by specific primers in segment 9. A PCR assay
was recently developed for LNV based on sequence of
segment 12 that allows detection of the genome in infect-
ed mouse blood (H. Attoui, unpub. data).
Treatment and Immunity
No specific treatment exists for infections caused by
any members of the family Reoviridae. In infections with
CTFV or BAV, symptomatic treatment includes acetamin-
ophen for relief of fever and pain. Patients infected with
CTFV show long-lasting immunity. An experimental vac-
cine was developed in the 1960s and produced long-lasting
immunity, but production was stopped in the 1970s.
Patients infected with BAV show a strong immunologic
response (35). Mice experimentally infected with BAV
develop viremia. Clearance of the virus from the circula-
tion occurs concomitantly with the appearance of anti-
BAV antibodies (36,40). 
Dr Attoui is a virologist at the university research unit in
Marseille, France. His research interest is human arboviruses of
the family Reoviridae (coltiviruses, seadornaviruses, and
orbiviruses).
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